Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

Clarus Corporation faces challenges but boasts insider buying and a 2.2% yield. See more about the investment potential of ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 23.80% ...

Raymond James has recently initiated Black Diamond Therapeutics Inc (BDTX) stock to Outper form rating, as announced on July 31, 2024, according to Finviz. Earlier, on July 14, 2023, Piper Sandler had ...

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...

Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Black Diamond Group Limited rents and sells modular ... including rental of accommodations and surface equipment, and provision of turnkey lodging and travel management logistics services in ...

Skiers and snowboarders can take advantage of HUGE savings on new and gently used winter gear with proceeds supporting the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...